Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
25.60 M
About CO.DON AG INH. O.N.
Sector
Industry
CEO
Ying Zhou
Website
Headquarters
Teltow
Founded
1999
ISIN
DE000A3E5C08
FIGI
BBG0069963V0
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. Its customers include accident surgeons, orthopaedic surgeons, and neurosurgeons in clinics and specialised practices. The firms main product Spherox is a three-dimensional chondrocyte product used to treat articular cartilage defects in the knee with autologous cells by means of matrix-associated autologous chondrocyte transplantation. The company was founded in 1993 and is headquartered in Teltow, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange CO.DON AG stocks are traded under the ticker CNW.
CO.DON AG is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track CO.DON AG financials in yearly and quarterly reports right on TradingView.
No, CNW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CNW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CO.DON AG stock right from TradingView charts — choose your broker and connect to your account.